Partners agree that the treatment of LUTS reduces patients' bother and improves their quality of life: Prospective 12 years follow-up study

World Journal of Urology

Volumn 28, Issue 1, 2010, Pages 123-132

  Mishriki, Said Fadel ^a   Grimsley, Samuel J S ^a   Nabi, Ghulam ^a   Cohen, Nicholas Paul ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Bother; BPE; LUTS; Partner; QoL; TURP

Indexed keywords

AGED; ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; PROSTATISM; QUALITY OF LIFE; SPOUSE; TIME;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATISM; QUALITY OF LIFE; SPOUSES; TIME FACTORS;

EID: 75849163895     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-009-0449-2     Document Type: Article

References (19)

1. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50: 1306-1314.
2. Roehrborn CG, Marks L, Harkaway R (2006) Enlarged prostate: a landmark national survey of its prevalence and impact on US men and their partners. Prostate Cancer Prostatic Dis 9: 30-34.
3. Trueman P, Hood SC, Nayak US, Mrazek MF (1999) Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK. BJU Int 83: 410-415.
4. Sells H, Donovan J, Ewings P, MacDonagh RP (2000) The development and validation of a quality-of-life measure to assess partner morbidity in benign prostatic enlargement. BJU Int 85: 440-445.
5. Shvartzman P, Borkan JM, Stoliar L, Peleg A, Nakar S, Nir G, Tabenkin H (2001) Second-hand prostatism: effects of prostatic symptoms on spouses' quality of life, daily routines and family relationships. Fam Pract 18: 610-613.
6. Mitropoulos D, Anastasiou I, Giannopoulou C, Nikolopoulos P, Alamanis C, Zervas A, Dimopoulos C (2002) Symptomatic benign prostate hyperplasia: impact on partners' quality of life. Eur Urol 41: 240-244.
7. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK (1992) American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148: 1549-1557.
8. Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs FD, Fourcade R, Kiemeney L, Lee C (2003) The prevalence of male urinary incontinence in four centres: the UREPIK study. BJU Int 92: 943-947.
9. Mishriki SF, Grimsley SJ, Nabi G, Martindale A, Cohen NP (2008) Improved quality of life and enhanced satisfaction after TURP: prospective 12-year follow-up study. Urology 72: 322-326 (discussion 326).
10. Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs R, Fourcade R, Kiemeney L, Lee C (2003) The relationship between lower urinary tract symptoms and health status: the UREPIK study. BJU Int 92: 575-580.
11. Welch G, Weinger K, Barry MJ (2002) Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. Urology 59: 245-250.
12. Zwergel U, Wullich B, Lindenmeir U, Rohde V, Zwergel T (1998) Long-term results following transurethral resection of the prostate. Eur Urol 33: 476-480.
13. Mishriki SF, Cohen NP, Mawas A, Banerjee G, Golash A, Mason R, Sutherland A (2001) LUTS bother partners too. BJU 88(Suppl 1): 58.
14. Roehrborn CG, Boyle P, Nickel JC, Hoefner K, Andriole G (2002) Efficacy and safety of a dual inhibitor of 5-apha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology 60: 434-441.
15. McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, Albertsen P, Roehrborn CG, Nickel JC, Wang DZ, Taylor AM, Waldstreicher J (1998) The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med 338: 557-563.
16. de la Rosette JJ, Kortmann BB, Rossi C, Sonke GS, Floratos DL, Kiemeney LA (2002) Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms. J Urol 167: 1734-1739.
17. Marklund-Bau H, Edéll-Gustafsson U, Spångberg A (2008) A Swedish version of a quality of life questionnaire for partners of men with symptoms suggestive of benign prostatic obstruction. Scand J Urol Nephrol 42: 126-131.
18. MacDonagh RP, Cliff AM, Speakman MJ, O'Boyle PJ, Ewings P, Gudex C (1997) The use of generic measures of health-related quality of life in the assessment of outcome from transurethral resection of the prostate. Br J Urol 79: 401-408.
19. Fowler FJ Jr, Wennberg JE, Timothy RP, Barry MJ, Mulley AG Jr, Hanley D (1988) Symptom status and quality of life following prostatectomy. JAMA 259: 3018-3022.